Asiaticoside alleviates migraine-induced cognitive impairment via TLR4-Mediated apoptosis regulation
European Journal of Pharmacology · 2025-11 · 1007 · 178204
DOI: 10.1016/j.ejphar.2025.178204 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025-11. Verfasst von Wei Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Apoptosis, Cognitive Dysfunction, Triterpenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Jilin Province.
Abstract (Originalsprache)
Migraine, a prevalent neurological disorder, is often accompanied by cognitive impairment that significantly reduces patients' quality of life. This study explored the therapeutic potential of Asiaticoside, a neuroprotective compound derived from Centella asiatica, in alleviating migraine-associated cognitive deficits. Using network pharmacology, we identified putative molecular targets of Asiaticoside and cross-referenced them with migraine- and cognitive impairment-related targets from GeneCards and OMIM databases. Protein-protein interaction networks were constructed, followed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses. In vivo validation was conducted using a nitroglycerin (NTG)-induced migraine mouse model, incorporating behavioral assessments alongside biochemical and molecular analyses. Network analysis highlighted the TLR4 signaling pathway and apoptosis as key mechanisms underlying Asiaticoside's therapeutic effects. Consistently, Asiaticoside dose-dependently alleviated NTG-induced nociceptive hypersensitivity and cognitive impairments. Mechanistically, Asiaticoside markedly inhibited the TLR4-MyD88-NF-κB signaling cascade and reduced the expression of pro-inflammatory cytokines and CGRP in the spinal trigeminal nucleus caudalis, prefrontal cortex, and hippocampus. Additionally, Asiaticoside attenuated neuronal apoptosis by modulating the balance of BCL-2 family proteins and suppressing Caspase-3 activation. Co-administration of the TLR4 inhibitor TAK-242 further enhanced Asiaticoside's protective effects. These findings collectively support that Asiaticoside alleviates migraine-induced cognitive impairments by modulating TLR4-mediated neuroinflammation and apoptosis, highlighting its promise as a potential therapeutic agent for migraine and its associated cognitive impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, China.
- Department of Ophthalmology, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun, 130041, China.
- Department of Thyroid Breast Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, 26 Shengli Street, Wuhan, 430014, China.
- Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, China. Electronic address: yang_yu@jlu.edu.cn.
- Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, China. Electronic address: dongge@jlu.edu.cn.
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Jilin Province
Zitieren
APA
Jiang, W., Feng, X. M., Yu, P., Zhang, L. X., Cai, M. T., Qu, K., Yang, Y., & Dong, M. (2025). Asiaticoside alleviates migraine-induced cognitive impairment via TLR4-Mediated apoptosis regulation. European Journal of Pharmacology, 1007, 178204. https://doi.org/10.1016/j.ejphar.2025.178204
Vancouver
Jiang W, Feng XM, Yu P, Zhang LX, Cai MT, Qu K, et al. Asiaticoside alleviates migraine-induced cognitive impairment via TLR4-Mediated apoptosis regulation. European Journal of Pharmacology. 2025;1007:178204. doi:10.1016/j.ejphar.2025.178204
BibTeX
@article{Jiang2025,
author = {Jiang, Wei and Feng, Xue-Min and Yu, Peng and Zhang, Li-Xi and Cai, Meng-Tan and Qu, Kang and Yang, Yu and Dong, Ming},
title = {Asiaticoside alleviates migraine-induced cognitive impairment via TLR4-Mediated apoptosis regulation},
journal = {European Journal of Pharmacology},
year = {2025},
volume = {1007},
pages = {178204},
doi = {10.1016/j.ejphar.2025.178204}
}
EUVIMED